UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

Research Progress of BRAF Fusion in Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2023-10, Vol.26 (10), p.782-788

2023

Volltextzugriff (PDF)

Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion

Frontiers in oncology, 2022-02, Vol.12, p.804330

2022

Volltextzugriff (PDF)

Chemotherapy-induced thrombocytopenia: literature review

Discover. Oncology, 2023-01, Vol.14 (1), p.10-10, Article 10

2023

Volltextzugriff (PDF)

TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study

Current oncology (Toronto), 2022-10, Vol.29 (10), p.7411-7419

2022

Volltextzugriff (PDF)

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

Current oncology (Toronto), 2022-09, Vol.29 (10), p.6749-6753

2022

Volltextzugriff (PDF)

2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells

PloS one, 2016-12, Vol.11 (12), p.e0168793

2016

Volltextzugriff (PDF)

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy

Frontiers in immunology, 2023-01, Vol.13, p.1068978

2023

Volltextzugriff (PDF)

EGFR p.V774M/p.L833V compound mutations in lung adenocarcinoma responded well to almonertinib: a case report

Frontiers in oncology, 2023-05, Vol.13, p.1159308

2023

Volltextzugriff (PDF)

Potential predictive value of comutant LRP1B and FAT for immune response in non-small cell lung cancer

Translational oncology, 2022-10, Vol.24, p.101493, Article 101493

2022

Volltextzugriff (PDF)

Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients

Chinese medical journal, 2023-06, Vol.136 (11), p.1370-1372

2023

Volltextzugriff (PDF)

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy

BMC cancer, 2023-07, Vol.23 (1), p.609-609, Article 609

2023

Volltextzugriff (PDF)

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

Frontiers in oncology, 2022-12, Vol.12, p.1035808-1035808

2022

Volltextzugriff (PDF)

CDK4/6 inhibitor palbociclib overcomes acquired resistance to third‐generation EGFR inhibitor osimertinib in non‐small cell lung cancer (NSCLC)

Thoracic cancer, 2020-09, Vol.11 (9), p.2389-2397

2020

Volltextzugriff (PDF)

CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression

Cell death & disease, 2024-05, Vol.15 (5), p.378-13, Article 378

2024

Volltextzugriff (PDF)

Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review

Zhongguo fei ai za zhi, 2023-02, Vol.26 (2), p.158-164

2023

Volltextzugriff (PDF)

Research Progress of Targeted Therapy for HER2 Gene  in Advanced Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2020-12, Vol.23 (12), p.1108-1112

2020

Volltextzugriff (PDF)

Salermide up‐regulates death receptor 5 expression through the ATF4‐ATF3‐CHOP axis and leads to apoptosis in human cancer cells

Journal of cellular and molecular medicine, 2012-07, Vol.16 (7), p.1618-1628

2012

Volltextzugriff (PDF)

Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR‐mutant non‐small cell lung cancer

Thoracic cancer, 2021-06, Vol.12 (11), p.1708-1715

2021

Volltextzugriff (PDF)

Gene Fusions as Acquired Resistance Mechanisms of EGFR-TKI

Zhongguo fei ai za zhi, 2020-05, Vol.23 (5), p.381-387

2020

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors Related Diabetes Mellitus:  A Report of 2 Cases and Literature Review

Zhongguo fei ai za zhi, 2022-01, Vol.25 (1), p.61-65

2022

Volltextzugriff (PDF)

Correlation Analysis between Neutrophil-to-lymphocyte Ratio  and the Risk of Malnutrition in Stage IV Primary Lung Cancer

Zhongguo fei ai za zhi, 2024-03, Vol.27 (3), p.193-198

2024

Volltextzugriff (PDF)

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

Molecular cancer, 2023-08, Vol.22 (1), p.124-124, Article 124

2023

Volltextzugriff (PDF)

Retrospective study of EGFR‐mutant lung adenocarcinoma with bone metastatic clinical features

Cancer reports, 2023-01, Vol.6 (1), p.e1628-n/a

2023

Volltextzugriff (PDF)

Immunotherapy in Epidermal Growth Factor Receptor-mutant  Non-small Cell Lung Cancer

Zhongguo Fei Ai Za Zhi, 2019-08, Vol.22 (8), p.541-545

2019

Volltextzugriff (PDF)

Clinical Development of Immunotherapy for Small Cell Lung Cancer

Zhongguo fei ai za zhi, 2018-12, Vol.21 (12), p.918-923

2018

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(157)

Publikationsform

Artikel
(156)
Berichte
(6)

Sprache

Englisch
(112)
Chinesisch
(52)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(80)
Science & Technology
(77)
Life Sciences & Biomedicine
(72)
Oncology
(55)
Lung Cancer
(54)
Mutation
(43)
Lung Neoplasms
(35)
Cancer Therapies
(31)
Lung Neoplasms - Genetics
(31)
Lung Neoplasms - Pathology
(28)
Chemotherapy
(24)
Female
(23)
Lung Neoplasms - Drug Therapy
(23)
Kinases
(22)
Epidermal Growth Factor
(21)
Metastasis
(21)
Carcinoma, Non-Small-Cell Lung - Genetics
(19)
Carcinoma, Non-Small-Cell Lung - Pathology
(19)
Aged
(18)
Male
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Research Progress of BRAF Fusion in Non-small Cell Lung Cancer

Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion

Chemotherapy-induced thrombocytopenia: literature review

TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy

EGFR p.V774M/p.L833V compound mutations in lung adenocarcinoma responded well to almonertinib: a case report

Potential predictive value of comutant LRP1B and FAT for immune response in non-small cell lung cancer

Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

CDK4/6 inhibitor palbociclib overcomes acquired resistance to third‐generation EGFR inhibitor osimertinib in non‐small cell lung cancer (NSCLC)

CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression

Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review

Research Progress of Targeted Therapy for HER2 Gene  in Advanced Non-small Cell Lung Cancer

Salermide up‐regulates death receptor 5 expression through the ATF4‐ATF3‐CHOP axis and leads to apoptosis in human cancer cells

Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR‐mutant non‐small cell lung cancer

Gene Fusions as Acquired Resistance Mechanisms of EGFR-TKI

Immune Checkpoint Inhibitors Related Diabetes Mellitus:  A Report of 2 Cases and Literature Review

Correlation Analysis between Neutrophil-to-lymphocyte Ratio  and the Risk of Malnutrition in Stage IV Primary Lung Cancer

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

Retrospective study of EGFR‐mutant lung adenocarcinoma with bone metastatic clinical features

Immunotherapy in Epidermal Growth Factor Receptor-mutant  Non-small Cell Lung Cancer

Clinical Development of Immunotherapy for Small Cell Lung Cancer

Suchergebnisse filtern